Modern mucolytic drug which provides physiological approach in treatment of diseases of the top and lower respiratory tracts. 

There are a lot of reasons of respiratory organs disease deelopment (major factors: infectious, allergic, autoimmune, hereditary). However the most common symptom of these diseases is cough. Competent treatment of cough is not suppression (cough promotes clarification of bronchial tubes from slime), but in transferring dry (unproductive) cough to damp (productive). Thus, the easy outflow of a phlegm and better drainage function of respiratory tracts is provided.

Drugs of a karbotsistein relating to group of mukomodificateurs are very importamt in caugh treatment. Such drug is Mucomilt. Мucomilt reduces the frequency and intensity of fits of coughing, improves the outflow of phlegms, oppresses inflammation mediators (at the expense of what the anti-inflammatory effect is reached), improves indicators of local immunity (IgA), increases efficiency of an antibiotics therapy and treatment in general, promotes restoration of sense of smell and hearing. Besides, Mucomilt reduces the frequency of recurrence of patients with chronic diseases of ENT organs.

Мucomilt is produced in three forms (tablets, syrup and capsules) that allows to provide an individual approach and to pick up a dosage form, optimum for each age. Syrup of Mucomilt is hypoallergenic (doesn’t contain dyes, and also sugar), with pleasant taste of fresh apple.

Read more about MUCOMILT